Cargando…

Shear Speed-Regulated Properties of Long-Acting Docetaxel Control Release Poly (Lactic-Co-Glycolic Acid) Microspheres

Advanced drug carriers for the controlled release of chemotherapeutics in the treatment of malignant tumors have drawn significant notice in recent years. In the current study, microspheres (MPs) loaded with docetaxel (DTX) were prepared using polylactic-co-glycolic acid copolymer (PLGA). The double...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yuhao, Sheng, Fan, Wang, Zihang, Yang, Guang, Li, Chenguang, Wang, He, Song, Zhiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468411/
https://www.ncbi.nlm.nih.gov/pubmed/32973517
http://dx.doi.org/10.3389/fphar.2020.01286
_version_ 1783578211726131200
author Zheng, Yuhao
Sheng, Fan
Wang, Zihang
Yang, Guang
Li, Chenguang
Wang, He
Song, Zhiming
author_facet Zheng, Yuhao
Sheng, Fan
Wang, Zihang
Yang, Guang
Li, Chenguang
Wang, He
Song, Zhiming
author_sort Zheng, Yuhao
collection PubMed
description Advanced drug carriers for the controlled release of chemotherapeutics in the treatment of malignant tumors have drawn significant notice in recent years. In the current study, microspheres (MPs) loaded with docetaxel (DTX) were prepared using polylactic-co-glycolic acid copolymer (PLGA). The double emulsion solvent evaporation method is simple to perform, and results in high encapsulation efficiency. Electron micrographs of the MPs showed that controlling the shear rate can effectively control the size of the MPs. At present, most DTX sustained-release carriers cannot maintain stable and long-term local drug release. The 1.68 μm DTX-loaded microspheres (MP/DTX) with elastase was completely degraded in 14 d. This controlled degradation period is similar to a course of treatment for most cancers. The drug release profile of all kinds of MP/DTX demonstrated an initial rapid release, then slower and stable release to the end. The current study demonstrates that it is possible to create drug-loaded MPs with specific degradation times and drug release curves, which may be useful in achieving optimal treatment times and drug release rates for different diseases, and different drug delivery routes. The initial burst release reaches the effective concentration of the drug at the beginning of release, and then the drug concentration is maintained by stable release to reduce the number of injections and improve patient compliance.
format Online
Article
Text
id pubmed-7468411
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74684112020-09-23 Shear Speed-Regulated Properties of Long-Acting Docetaxel Control Release Poly (Lactic-Co-Glycolic Acid) Microspheres Zheng, Yuhao Sheng, Fan Wang, Zihang Yang, Guang Li, Chenguang Wang, He Song, Zhiming Front Pharmacol Pharmacology Advanced drug carriers for the controlled release of chemotherapeutics in the treatment of malignant tumors have drawn significant notice in recent years. In the current study, microspheres (MPs) loaded with docetaxel (DTX) were prepared using polylactic-co-glycolic acid copolymer (PLGA). The double emulsion solvent evaporation method is simple to perform, and results in high encapsulation efficiency. Electron micrographs of the MPs showed that controlling the shear rate can effectively control the size of the MPs. At present, most DTX sustained-release carriers cannot maintain stable and long-term local drug release. The 1.68 μm DTX-loaded microspheres (MP/DTX) with elastase was completely degraded in 14 d. This controlled degradation period is similar to a course of treatment for most cancers. The drug release profile of all kinds of MP/DTX demonstrated an initial rapid release, then slower and stable release to the end. The current study demonstrates that it is possible to create drug-loaded MPs with specific degradation times and drug release curves, which may be useful in achieving optimal treatment times and drug release rates for different diseases, and different drug delivery routes. The initial burst release reaches the effective concentration of the drug at the beginning of release, and then the drug concentration is maintained by stable release to reduce the number of injections and improve patient compliance. Frontiers Media S.A. 2020-08-20 /pmc/articles/PMC7468411/ /pubmed/32973517 http://dx.doi.org/10.3389/fphar.2020.01286 Text en Copyright © 2020 Zheng, Sheng, Wang, Yang, Li, Wang and Song http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zheng, Yuhao
Sheng, Fan
Wang, Zihang
Yang, Guang
Li, Chenguang
Wang, He
Song, Zhiming
Shear Speed-Regulated Properties of Long-Acting Docetaxel Control Release Poly (Lactic-Co-Glycolic Acid) Microspheres
title Shear Speed-Regulated Properties of Long-Acting Docetaxel Control Release Poly (Lactic-Co-Glycolic Acid) Microspheres
title_full Shear Speed-Regulated Properties of Long-Acting Docetaxel Control Release Poly (Lactic-Co-Glycolic Acid) Microspheres
title_fullStr Shear Speed-Regulated Properties of Long-Acting Docetaxel Control Release Poly (Lactic-Co-Glycolic Acid) Microspheres
title_full_unstemmed Shear Speed-Regulated Properties of Long-Acting Docetaxel Control Release Poly (Lactic-Co-Glycolic Acid) Microspheres
title_short Shear Speed-Regulated Properties of Long-Acting Docetaxel Control Release Poly (Lactic-Co-Glycolic Acid) Microspheres
title_sort shear speed-regulated properties of long-acting docetaxel control release poly (lactic-co-glycolic acid) microspheres
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468411/
https://www.ncbi.nlm.nih.gov/pubmed/32973517
http://dx.doi.org/10.3389/fphar.2020.01286
work_keys_str_mv AT zhengyuhao shearspeedregulatedpropertiesoflongactingdocetaxelcontrolreleasepolylacticcoglycolicacidmicrospheres
AT shengfan shearspeedregulatedpropertiesoflongactingdocetaxelcontrolreleasepolylacticcoglycolicacidmicrospheres
AT wangzihang shearspeedregulatedpropertiesoflongactingdocetaxelcontrolreleasepolylacticcoglycolicacidmicrospheres
AT yangguang shearspeedregulatedpropertiesoflongactingdocetaxelcontrolreleasepolylacticcoglycolicacidmicrospheres
AT lichenguang shearspeedregulatedpropertiesoflongactingdocetaxelcontrolreleasepolylacticcoglycolicacidmicrospheres
AT wanghe shearspeedregulatedpropertiesoflongactingdocetaxelcontrolreleasepolylacticcoglycolicacidmicrospheres
AT songzhiming shearspeedregulatedpropertiesoflongactingdocetaxelcontrolreleasepolylacticcoglycolicacidmicrospheres